Navigation Links
New MagnaBloc™ Product Available from Gradient Medical
Date:7/2/2008

Gradient Medical recently started offering QuadraBloc™, a new and improved version of AmWay's MagnaBloc.

Memphis, TN (PRWEB) July 2, 2008 -- AmWay's MagnaBloc™, a long-popular form of pain management, is now available in a new, stronger form: QuadraBloc™, offered by Gradient Medical.

"QuadraBloc has already been released in the United States, and will be available worldwide within 60 sixty days," said John Townsend, President of Gradient Medical, LLC. "We will also be releasing several new products within the next few weeks."

Put simply, the QuadraBloc uses magnetic principles to disrupt the transduction of the electrochemical pain signals to the brain. QuadraBloc uses not one but four magnets and a focusing ring placed in a square or diamond pattern. For maximum pain management the QuadraBloc is placed directly over the irritated nerve, where the gradient of the magnetic field has the strongest impact on the nerve's pain signal.

"QuadraBloc is between two and four times stronger than MagnaBloc," Townsend said. "This technology offers an alternative for superior pain relief for people with back pain, sports injuries, and other sources of chronic pain."

The principles that the QuadraBloc is based on were first published in Environmental Science in 1991. In addition, the device's effectiveness is supported by more than a decade of cell research at the Vanderbilt University School of Medicine and at the Center for Pain Research and Neuromagnetics at the University Medical Center in Nashville, Tennessee, as well as numerous other studies performed around the world. To eliminate the experimenters' biases, several of the studies done have been "double blinded," which is where neither the doctor nor the patient know which group the patient is in: the experimental group, which uses the QuadraBloc device, or the control group, which uses a "placebo" or a dummy device.

"The principles used in creating the QuadraBloc have been scientifically researched and well documented," Townsend said. "All of the results to date demonstrate that QuadraBlocs are safe, low in cost and remarkably effective in treating a large variety of aches and pains."

Townsend indicated that the product has not been approved by FDA, has been sold as an OTC product in 40 countries including the US and is not intended to obviate the need to seek professional assistance for health care professionals.

For more information about Gradient Medical and the QuadraBloc™, including laboratory results, videos, and testimonials, please visit www.QuadraBloc.com.

About Gradient Medical, LLC:
The owner of multiple patents for the design and use of QuadraBlocs, Gradient Medical, LLC is a pioneer in the field of using magnets for health. After AmWay's 10-year license of MagnaBloc expired in April of 2008, Gradient Medical launched the QuadraBloc, which offers non surgical and non drug alternatives for the management of pain. For more information about Gradient Medical's products, including the QuadraBloc, please visit http://www.QuadraBloc.com.

###


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. The Quantum Group Adds New Insurance Product for Physicians
2. Release of Kowalski Book on Attaining Healthy Blood Pressure Coincides with Website Launch, New Endurance Products SR L-Arginine and Grape Seed Extract
3. Labopharm Receives Response from FDA Regarding its Once-Daily Tramadol Product
4. Birchwood Laboratories Expands B-SURE™ Incontinence and Personal Care Product Line™; Three New Products Added Including B-SURE Fresh 'n Go™, B-SURE Bottom Balm™ and B-SURE Traveler™
5. Best Practice Database Adds Research on New Product Commercialization
6. StrionAir System A130 Air Purification Product Reduces Fan Energy by More Than 10 Percent
7. NSF International Certifies Purity of Four Mannatech Products
8. HighPoint Solutions Develops Novel Incentive Compensation Plan for New Benign Prostatic Hyperplasia (BPH) Product
9. Bioniche Secures Final Financing to Scale-up E. coli O157:H7 Vaccine Production
10. Function Drinks Launches New Product to Support Sexual Health
11. Blue Cross and Blue Shield of Georgia Introduces New Individual Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... July 20, 2017 , ... TCGRx announced today at ... adherence automation lines. The ATP® Mini and InspectRx® Mini are designed ... products, but at a size and price point that can help pharmacies launch ...
(Date:7/20/2017)... Charlotte, NC (PRWEB) , ... July 20, 2017 , ... ... announces the latest innovation to their product line: the AVE 2 birthing bed. , ... 2 helps bring a new level of comfort and efficiency to every phase of ...
(Date:7/20/2017)... ... July 19, 2017 , ... Western University of Health ... Administration (HRSA) grant to train predoctoral dental students in providing care to vulnerable ... underserved areas. , The Predoctoral Pediatric Training Project (PPTP), a five-year grant, recognizes ...
(Date:7/20/2017)... ... ... the Buffalo and Her Adventures”: a collection of heartwarming children’s stories. “Lucky the Buffalo ... Jr. was born in Toledo, Ohio. He attended Woodward High School. He earned ... to a brilliant woman with a caring heart named Tiina, who is a hospice nurse. ...
(Date:7/18/2017)... ... 18, 2017 , ... Doctors on Liens, the leading network ... professionals who offer the most effective and efficient care on a lien basis. ... that each patient receives prompt and courteous service, same or next day appointments, ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... 2017  Bayer has awarded grants totaling more than $2 ... its prestigious Bayer Hemophilia Awards Program (BHAP). Four U.S. clinicians ... and Uniformed Services University of the Health Sciences ... Grant recipients were announced last night during a reception at ... Berlin, Germany . ...
(Date:7/11/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... has agreed to schedule an End-of-Phase II meeting with ... its oral insulin capsule ORMD-0801 in the treatment of ... and secondary endpoints by indicating a statistically significant lowering ...
(Date:7/10/2017)... , July 10, 2017  The tenth annual ... Boston, MA at the Sheraton Boston ... and unparalleled access to global decision makers and innovative ... 800+ life science leaders during two impactful days. BioPharm ... provides delegates with additional networking opportunities with 4,500+ life ...
Breaking Medicine Technology: